SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Mellalta Meets LLP | PRODUCT CODE: 2117166

Cover Image

PUBLISHER: Mellalta Meets LLP | PRODUCT CODE: 2117166

PFAS Restrictions in the EU and US: Impact on Fluoromaterials Suppliers | Market Intelligence | US, EU5, Japan & China

PUBLISHED:
PAGES: 160 Pages
DELIVERY TIME: 7-10 business days
SELECT AN OPTION
PPT (Single User License)
USD 6900
PPT (2 - 3 User License)
USD 7500
PPT (Site License - Up to 10 Users)
USD 10500
PPT (Enterprise License)
USD 15500

Add to Cart

Few regulatory files matter more to the fluorochemicals industry than the proposed European Union restriction on PFAS - per- and polyfluoroalkyl substances. Fluoropolymers such as PTFE, PFA, FEP, and PVDF carry properties no other polymer family matches: chemical inertness, temperature resistance, dielectric performance, and low friction. They line chemical plants, insulate semiconductor fabs, seal automotive systems, and form the membranes inside electrolyzers and fuel cells. Japanese producers - Daikin with its Neoflon family and AGC with Fluon, Cytop, and FORBLUE - are among the world's leading suppliers, alongside Chemours, Syensqo, Arkema, and until recently 3M. The EU's universal PFAS restriction proposal and parallel US actions put the industry's regulatory foundation in question.

The tension is between hazard-based regulation and irreplaceable function. The restriction proposal treats fluoropolymers within the broad PFAS definition, which the industry contests on the grounds that these high-molecular-weight polymers behave differently from the small-molecule PFAS of concern; regulators respond with persistence arguments and manufacturing-emission concerns. Meanwhile 3M's exit from PFAS manufacturing by end-2025 has already removed a major supply source, pushing customers to requalify alternatives and tightening the market that remains. Chinese producers - Juhua, Dongyue, Sinochem - expand capacity behind the restriction debate, raising the prospect that a European ban would shift production rather than eliminate it. Exemption categories for semiconductors, energy, and medical uses are being negotiated use by use, and the outcome will determine which fluoromaterials businesses remain viable in Europe.

This report maps the PFAS restriction landscape and its impact on Japanese fluoromaterials suppliers. It explains the EU restriction proposal's structure, timeline, and derogation architecture; surveys US federal and state actions; profiles each producer's fluoropolymer and fluorochemical portfolio and exposure; and examines substitution options and their limits in key applications. It answers which products face restriction, which uses are likely to receive derogations, how customers are requalifying after the 3M exit, and how Japanese suppliers are positioning.

The report is written for chemical company strategists, OEM materials engineers with fluoropolymer dependence, regulatory affairs teams, and investors assessing regulatory risk in specialty chemicals. It is used as a regulation tracker, a product-exposure map, and a substitution reference.

Scope and Coverage: The report covers the EU universal PFAS restriction proposal, US EPA and state-level PFAS actions, fluoropolymer and fluorochemical portfolios of Japanese, Western, and Chinese producers, and application-level substitution analysis, documented through 2026.

Report Highlights:

  • Structured explanation of the EU universal PFAS restriction proposal and its derogation architecture
  • Product-level exposure mapping for Daikin Neoflon and AGC Fluon, Cytop, and FORBLUE lines
  • The 3M exit from PFAS manufacturing and its requalification consequences
  • Western competitor profiles: Chemours, Syensqo, Arkema, W. L. Gore, Honeywell, Saint-Gobain
  • Chinese fluoropolymer expansion mapped against the Western restriction debate
  • Application-by-application substitution analysis for semiconductors, energy, automotive, and medical uses
Product Code: JPH-086

Table of Content

1. Executive Summary

2. PFAS Restrictions in the EU and US: Product and Technology Segments Covered

3. Japanese Supplier Landscape and Market Positions

4. US and Europe Expansion: Plants, Deals, and Timelines

5. Trade and Regulatory Framework: Tariffs, REACH, and Subsidy Programs

6. Customer Qualification Processes and Supply Agreements

7. Competitive Dynamics: Japanese, US, European, and Chinese Suppliers

8. Outlook and Key Watch Items

9. Appendix: Methodology and Sources

Companies Mentioned

  • Daikin (JP) - Neoflon fluoropolymers (PTFE/PFA/FEP) and refrigerants exposed to PFAS rules
  • AGC (JP) - Fluon fluoropolymers, Cytop amorphous fluoropolymer, FORBLUE membranes
  • Chemours (US) - Teflon fluoropolymers and Nafion membranes
  • 3M (US) - exiting PFAS manufacturing by end-2025
  • Solvay/Syensqo (BE) - fluoropolymer and fluoroelastomer specialty portfolio
  • Arkema (FR) - Kynar PVDF and Forane refrigerants
  • W. L. Gore (US) - PTFE membrane products
  • Honeywell (US) - fluorochemicals and Solstice low-GWP line
  • Saint-Gobain (FR) - PTFE-lined and fluoropolymer components
  • Juhua Group (CN) - fluoropolymer producer
  • Dongyue Group (CN) - PTFE/PVDF producer
  • Sinochem (CN) - fluorochemicals group
Product Code: JPH-086

List of Tables

  • Table 1. PFAS definition and chemistry: polymers versus non-polymers
  • Table 2. Fluoropolymer family tree: PTFE, PFA, FEP, PVDF, ETFE, and specialty grades
  • Table 3. Fluoropolymer property set and irreplaceable functions
  • Table 4. EU universal PFAS restriction proposal: structure and scope
  • Table 5. EU restriction proposal timeline: submission, evaluation, and opinions
  • Table 6. Derogation categories under discussion in the EU process
  • Table 7. ECHA committee evaluation process for the PFAS restriction
  • Table 8. Industry submissions and stakeholder positions in the EU process
  • Table 9. US EPA PFAS actions relevant to fluoropolymers
  • Table 10. US state-level PFAS legislation affecting fluoromaterials
  • Table 11. Japanese PFAS regulatory developments
  • Table 12. Daikin Neoflon fluoropolymer product family
  • Table 13. Daikin fluorochemical and refrigerant portfolio exposure
  • Table 14. Daikin production footprint for fluoromaterials
  • Table 15. AGC Fluon fluoropolymer product family
  • Table 16. AGC Cytop amorphous fluoropolymer applications
  • Table 17. AGC FORBLUE membrane exposure to PFAS rules
  • Table 18. Chemours Teflon fluoropolymer portfolio
  • Table 19. Chemours Nafion membrane position and PFAS exposure
  • Table 20. 3M PFAS manufacturing exit: announced scope and end-2025 timeline
  • Table 21. 3M exit consequences for customer supply arrangements
  • Table 22. Syensqo fluoropolymer and fluoroelastomer portfolio
  • Table 23. Arkema Kynar PVDF operations
  • Table 24. Arkema Forane refrigerant exposure
  • Table 25. W. L. Gore PTFE membrane product exposure
  • Table 26. Honeywell fluorochemicals and Solstice low-GWP line
  • Table 27. Saint-Gobain fluoropolymer component operations
  • Table 28. Juhua Group fluoropolymer operations
  • Table 29. Dongyue Group PTFE and PVDF operations
  • Table 30. Sinochem fluorochemicals operations
  • Table 31. Chinese fluoropolymer capacity expansion programs
  • Table 32. Semiconductor manufacturing applications for fluoropolymers
  • Table 33. Semiconductor equipment components: seals, linings, and tubing
  • Table 34. Energy applications: electrolyzer and fuel cell membranes
  • Table 35. Battery applications: PVDF binders and separator coatings
  • Table 36. Automotive applications: seals, hoses, and wire insulation
  • Table 37. Chemical processing applications: linings and gaskets
  • Table 38. Medical and pharmaceutical applications for fluoropolymers
  • Table 39. Cookware and consumer applications and their regulatory status
  • Table 40. Wire and cable applications in aerospace and data centers
  • Table 41. Substitution options for fluoropolymer linings and seals
  • Table 42. Substitution options for fluoropolymer membranes
  • Table 43. Substitution options for PVDF battery binders
  • Table 44. Performance gaps of non-fluorinated alternatives
  • Table 45. Refrigerant transition regulations: F-gas rules in the EU and US
  • Table 46. Refrigerant portfolio transitions at Daikin and competitors
  • Table 47. PFAS manufacturing emission controls and remediation obligations
  • Table 48. PFAS litigation and liability landscape relevant to producers
  • Table 49. Customer requalification programs after the 3M exit
  • Table 50. Japanese fluoromaterials supplier strategy comparison

List of Figures

  • Figure 1. PFAS chemistry map: polymers and non-polymers
  • Figure 2. Fluoropolymer family tree and property ladder
  • Figure 3. Fluoropolymer application map by function
  • Figure 4. EU universal PFAS restriction proposal structure
  • Figure 5. EU restriction process timeline through 2026
  • Figure 6. Derogation architecture under discussion
  • Figure 7. ECHA committee evaluation workflow
  • Figure 8. Stakeholder position map in the EU PFAS process
  • Figure 9. US federal PFAS action map
  • Figure 10. US state PFAS legislation map
  • Figure 11. Japanese PFAS regulatory timeline
  • Figure 12. Daikin fluoromaterials portfolio map
  • Figure 13. Daikin fluoromaterials production footprint
  • Figure 14. AGC fluoromaterials portfolio map
  • Figure 15. AGC Cytop and FORBLUE application map
  • Figure 16. Chemours fluoropolymer portfolio map
  • Figure 17. 3M PFAS exit timeline and product consequences
  • Figure 18. Syensqo and Arkema fluoropolymer portfolio map
  • Figure 19. W. L. Gore, Honeywell, and Saint-Gobain exposure map
  • Figure 20. Chinese fluoropolymer producer expansion map
  • Figure 21. Global fluoropolymer supply structure before and after the 3M exit
  • Figure 22. Semiconductor fab fluoropolymer application map
  • Figure 23. Semiconductor equipment component map: seals and linings
  • Figure 24. Electrolyzer and fuel cell membrane exposure map
  • Figure 25. Battery binder and separator coating exposure map
  • Figure 26. Automotive fluoropolymer application map
  • Figure 27. Chemical plant lining and gasket application map
  • Figure 28. Medical fluoropolymer application map
  • Figure 29. Wire and cable fluoropolymer application map
  • Figure 30. Substitution option map for linings and seals
  • Figure 31. Substitution option map for membranes
  • Figure 32. Substitution option map for battery binders
  • Figure 33. Performance gap chart: non-fluorinated alternatives (schematic)
  • Figure 34. F-gas regulation timeline in the EU and US
  • Figure 35. Refrigerant portfolio transition map
  • Figure 36. PFAS emission control and remediation obligation map
  • Figure 37. PFAS litigation landscape map
  • Figure 38. Customer requalification workflow after supplier exit
  • Figure 39. Application-level regulatory exposure matrix
  • Figure 40. Producer-level regulatory exposure matrix
  • Figure 41. Restriction outcome scenario tree for fluoropolymers
  • Figure 42. Supply shift scenarios toward Chinese production
  • Figure 43. Derogation scenario map by application
  • Figure 44. Japanese supplier positioning matrix under restriction scenarios
  • Figure 45. Western supplier positioning matrix under restriction scenarios
  • Figure 46. Substitution investment map by application
  • Figure 47. Regulatory monitoring framework for PFAS files
  • Figure 48. Fluoromaterials demand scenario tree, 2026-2035
  • Figure 49. Japanese fluoromaterials strategy archetypes
  • Figure 50. Report methodology and source map
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!